FDA Drug Application (203323) for AMIKACIN SULFATE by SAGENT PHARMS

Back to FDA Applications sponsored by SAGENT PHARMS

Application Number203323
Product Number001
FormINJECTABLE;INJECTION
DosageEQ 250MG BASE/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameAMIKACIN SULFATE
Active IngredientAMIKACIN SULFATE

Active IngredientCount
List of drugs with Active Ingredient AMIKACIN SULFATE4


Back to FDA Applications sponsored by SAGENT PHARMS